Æterna Zentaris, Inc.
(Toronto Stock Exchange : AEZS)

( )
AEZS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.94%245.371.5%$940.74m
MRNAModerna, Inc. 0.71%144.270.0%$849.73m
REGNRegeneron Pharmaceuticals, Inc. 0.84%612.492.6%$526.18m
VRTXVertex Pharmaceuticals, Inc. 3.19%292.551.9%$516.29m
GILDGilead Sciences, Inc. 0.80%63.081.0%$513.27m
NVAXNovavax, Inc. -0.27%51.6775.7%$422.21m
ILMNIllumina, Inc. 0.20%193.933.3%$361.41m
BIIBBiogen, Inc. 0.26%211.931.8%$242.32m
SNSSSunesis Pharmaceuticals, Inc. 9.63%2.960.7%$206.91m
CRSPCRISPR Therapeutics AG 2.78%66.960.6%$173.29m
BNTXBioNTech SE 1.32%134.040.0%$153.17m
BMRNBioMarin Pharmaceutical, Inc. 2.72%86.854.2%$121.28m
EXASEXACT Sciences Corp. 6.89%45.1517.7%$107.32m
IOVAIovance Biotherapeutics, Inc. 0.19%10.350.0%$103.94m
TECHBio-Techne Corp. 2.16%352.764.5%$95.22m

Company Profile

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.